FdaApplication

ANDA 214348

Back to search

Identifiers

Properties

PropertyValue
applicant_nameJIANGSU HENGRUI PHARMACEUTICALS CO LTD
application_typeANDA
approval_date2024-07-01

Products (2)

ProductActive ingredientStrengthDosage form
BUPIVACAINE LIPOSOMEBUPIVACAINE266MG/20ML (13.3MG/ML)INJECTABLE, LIPOSOMAL;INJECTION
BUPIVACAINE LIPOSOMEBUPIVACAINE133MG/10ML (13.3MG/ML)INJECTABLE, LIPOSOMAL;INJECTION

2 products